Eris Lifesciences has confirmed compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The confirmation certificate was received from their Registrar and Share Transfer Agent, MUFG Intime India Private Limited.
Compliance Confirmation
Eris Lifesciences has received confirmation regarding compliance with regulatory requirements for handling dematerialization requests.
Details of Compliance
A certificate was received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA), regarding the handling of securities received for dematerialization during Q3 2025 (October-December). This certificate confirms that the securities received for dematerialization have been duly processed.
MUFG Intime India Private Limited confirmed that the securities received from depository participants for dematerialization during the quarter ended December 31, 2025, were confirmed to the depositories. The securities comprised in the certificates have been listed on the stock exchanges where the earlier issued securities are listed.
The security certificates received for dematerialization have been confirmed, and after due verification, the certificates were mutilated and cancelled. The names of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines.
Source: BSE
